• 1. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
• 2. An approach to C–N activation: coupling of arenesulfonyl hydrazides and arenesulfonyl chlorides with tert-amines via a metal-, oxidant- and halogen-free anodic oxidation??
  M. Sheykhan,S. Khani,S. Shaabanzadeh,M. Joafshan Green Chem., 2017,19, 5940-5948
• 3. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 4. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 5. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzimidazoles Benzimidazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzimidazoles

Recent Advances in the Study of 1H-Benzimidazole,7-nitro-2-(trifluoromethyl)- (CAS: 14689-51-1)

The compound 1H-Benzimidazole,7-nitro-2-(trifluoromethyl)- (CAS: 14689-51-1) has garnered significant attention in recent years due to its potential applications in medicinal chemistry and drug development. This heterocyclic compound, characterized by a benzimidazole core substituted with a nitro group at the 7-position and a trifluoromethyl group at the 2-position, exhibits unique physicochemical properties that make it a promising candidate for various therapeutic applications. Recent studies have focused on its synthesis, biological activity, and potential as a scaffold for novel drug candidates.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers explored the antimicrobial properties of 1H-Benzimidazole,7-nitro-2-(trifluoromethyl)-. The study demonstrated that this compound exhibits potent activity against a range of Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The presence of the nitro and trifluoromethyl groups was found to enhance the compound's ability to penetrate bacterial cell membranes and inhibit key enzymes involved in bacterial DNA replication. These findings suggest that derivatives of this compound could be developed as novel antibiotics to address the growing problem of antimicrobial resistance.

Another significant area of research involves the anticancer potential of 1H-Benzimidazole,7-nitro-2-(trifluoromethyl)-. A 2022 study in Bioorganic & Medicinal Chemistry Letters reported that this compound shows selective cytotoxicity against certain cancer cell lines, particularly those associated with colorectal and pancreatic cancers. Mechanistic studies revealed that the compound induces apoptosis through the activation of caspase-3 and caspase-9, while also inhibiting the PI3K/AKT/mTOR signaling pathway. The trifluoromethyl group was identified as a critical moiety for enhancing the compound's bioavailability and target specificity.

The synthesis and optimization of 1H-Benzimidazole,7-nitro-2-(trifluoromethyl)- have also been a focus of recent research. A 2023 paper in Tetrahedron Letters described a novel, high-yield synthetic route for this compound using a palladium-catalyzed cross-coupling reaction. This method offers advantages over traditional approaches, including shorter reaction times and higher purity of the final product. Additionally, computational studies have been employed to predict the compound's ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties, aiding in the design of more effective derivatives.

Despite these promising findings, challenges remain in the development of 1H-Benzimidazole,7-nitro-2-(trifluoromethyl)- as a therapeutic agent. Issues such as solubility, metabolic stability, and potential off-target effects need to be addressed through further structural modifications and preclinical studies. However, the compound's versatile scaffold and demonstrated biological activities make it a valuable subject for ongoing research in the field of chemical biology and medicinal chemistry.

• 14689-58-8(5-bromo-4-nitro-2-(trifluoromethyl)-1H-1,3-benzodiazole)
• 51026-15-4(1H-Benzimidazole,2-ethyl-7-nitro-5-(trifluoromethyl)-)
• 89843-49-2(1H-Benzimidazole, 6-nitro-2-(trifluoromethyl)-)
• 327-19-5(5-Nitro-2-(trifluoromethyl)-1H-benzimidazole)
• 14863-50-4(1H-Benzimidazole,5,7-dichloro-4,6-dinitro-2-(trifluoromethyl)-)
• 2338-24-1(1H-Benzimidazole,5,6-dinitro-2-(trifluoromethyl)-)
• 92335-67-6(1H-Benzimidazol-4-amine,2-methyl-7-nitro-)
• 97273-25-1(2-(Difluoromethyl)-5-nitro-1H-benzo[d]imidazole)
• 76320-88-2(2-Methyl-4-nitro-1H-benzodimidazole)
• 60167-90-0(1H-Benzimidazole, 4-methyl-5,7-dinitro-2-(trifluoromethyl)-)